GSK’s £1.4bn breaks coupon records as 2012 ends on a high

GlaxoSmithKline, the UK pharmaceutical company, launched its first sterling bonds this week for nearly five years, achieving strong demand and raising £1.4bn in the second biggest corporate issue of the year in the currency.